The following table or figure may be downloaded to PowerPoint for personal use in teaching and presentations. This feature is available to all subscribers to the journal.

You MUST read and follow the guidelines at Request to Reproduce AJR Content if you are distributing or using AJR content beyond academic use (limited distribution, non-revenue producing, or educational purposes).

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1 —Flow diagram depicts manner in which patients were selected. Top three boxes describe procedures completed for clinical care. Bottom five boxes describe procedures completed for research study. Inclusion criteria were double-contrast MRI performed, cirrhosis histologically confirmed, and liver explant examined after double-contrast MRI examination. Exclusion criteria were ablative therapy before study MRI and liver explant performed more than 12 months after MRI in patients in whom explant had positive results for hepatocellular carcinoma (HCC). For patients in whom explant had negative results for HCC, MRI-explant interval greater than 12 months was acceptable, and such patients were not excluded.